Long-acting muscarinic receptor antagonists for the treatment of respiratory disease-Reference-Cited by-同舟云学术

Long-acting muscarinic receptor antagonists for the treatment of respiratory disease

Published:2013-06 Issue:3 Volume:26 Page:307-317
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Cazzola Mario,Page Clive,Matera Maria Gabriella

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference106 articles.

1. Chronic obstructive pulmonary disease: molecular and cellular mechanisms;Barnes;Eur Respir J,2003

2. Chronic obstructive pulmonary disease: an overview of pathology and pathogenesis;Hogg;Novartis Found Symp,2001

3. Reflex regulation of airway smooth muscle tone;Canning;J Appl Physiol,2006

4. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care;National Clinical Guideline Centre,2010

5. Inhaled corticosteroids for the treatment of chronic asthma in adults and children aged 12 years and over;National Institute for Health and Clinical Excellence,2008

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Molecular Mechanisms and Biomarkers in COPD: An Overview of Current Advancements and Perspectives;International Journal of Molecular Sciences;2024-07-04

2. Cardiovascular Events with the Use of Long-Acting Muscarinic Receptor Antagonists: An Analysis of the FAERS Database 2020–2023;Lung;2024-02-06

3. Signal Mining and Analysis of Cardiovascular Adverse Events of Tiotropium Bromide Based on the FAERS Database;Advances in Clinical Medicine;2024

4. Is it preferable to administer a bronchodilator once- or twice-daily when treating COPD?;Respiratory Medicine;2023-11

5. Mucus Hypersecretion in Chronic Obstructive Pulmonary Disease and Its Treatment;Mediators of Inflammation;2023-07-06